HMGB1 and fibrosarcoma: Further, Wang et al. found that, when combined with a low dose of OXA, thiostrepton, an antibiotic produced by Streptomyces, can enhance anti-cancer immunogenicity by promoting the release of ATP and HMGB1, as well as CRT exposure, in mouse fibrosarcoma cells (Wang Y. et al., 2020).